FibroGenesis is a regenerative medicine company that focuses on developing a pioneering solution for degenerative disc disease through the use of human dermal fibroblasts. With a portfolio boasting 150+ U.S. and international issued patents issued/pending, FibroGenesis is at the forefront of medical advancement in cell therapy.
There is no investment information
No recent news or press coverage available for FibroGenesis.
We care about your data, and we'd love to use cookies make your experience better.